Genetic characteristics of H1N1 influenza virus outbreak in China in early 2023

Abstract

Electronic Supplementary Material

10.1016j.virs.2024.05.003-ESM.docx

References

1. Bi,Y., Chen, Q., Wang, Q., Chen, J., Jin, T., Wong, G., Quan, C., Liu, J., Wu, J., Yin, R., Zhao, L., Li, M., Ding, Z., Zou, R., Xu, W., Li, H., Wang, H., Tian, K., Fu, G., Yu, H., Alexander, S., Li, S., Xu, B., Yu, H., Luo, T., Lu, X., Xu, X., Luo, Y., Liu, Y., Shi, W., Liu, D., Gao, G.F., 2016. Genesis, evolution and prevalence of H5N6 avian influenza viruses in China. Cell Host Microbe 20, 810-821.
   

2. Bi, Y., Li, J., Li, S., Fu, G., Jin, T., Zhang, C., Yang, Y., Ma, Z., Tian, W., Li, J.D., Xiao, S., Li, L., Yin, R., Zhang, Y., Wang, L., Qin, Y., Yao, Z., Meng, F., Hu, D., Li, D., Wong, G., Liu, F., Lv, N., Wang, L., Fu, L., Yang, Y., Peng, Y., Ma, J., Sharshov, K., Shestopalov, A., Gulyaeva, M., Gao, G.F., Chen, J., Shi, Y., Liu, W.J., Chu, D., Huang, Y., Liu, Y., Liu, L., Liu, W., Chen, Q., Shi, W., 2020. Dominant subtype switch in avian influenza viruses during 2016-2019 in China. Nat. Commun. 11, 5909.
   

3. Hay, A.J., Gregory, V., Douglas, A.R., Lin, Y., 2001. The evolution of human influenza viruses. Phil. Trans. Roy. Soc. Lond. B 356(1416), 1861-1870.
   

4. Kimura, M., 1980. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16, 111-120.
   

5. Liu, M., Liu, J., Song, W., Peng, Y., Ding, X., Deng, L., Jiang, T., 2023. Development of PREDAC-H1pdm to model the antigenic evolution of influenza A/(H1N1) pdm09 viruses. Virol. Sin. 38, 541-548.
   

6. Mohan, T., Nguyen, H.T., Kniss, K., Mishin, V.P., Merced-Morales, A.A., Laplante, J., St George, K., Blevins, P., Chesnokov, A., De La Cruz, J.A., Kondor, R., Wentworth, D.E., Gubareva, L.V., 2021. Cluster of oseltamivir-resistant and hemagglutinin antigenically drifted influenza A (H1N1) pdm09 viruses, Texas, USA, January 2020. Emerg. Infect. Dis. 27, 1953-1957.
   

7. Naffakh, N., Werf, S.V.D., 2009. April 2009: an outbreak of swine-origin influenza A (H1N1) virus with evidence for human-to-human transmission. Microb. Infect. 11, 725-728.
   

8. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360, 2605-2615.
   

9. Olsen, S.J., Winn, A.K., Budd, A.P., Prill, M.M., Steel, J., Midgley, C.M., Kniss, K., Burns, E., Rowe, T., Foust, A., Jasso, G., Merced-Morales, A., Davis, C.T., Jang, Y., Jones, J., Daly, P., Gubareva, L., Barnes, J., Kondor, R., Sessions, W., Smith, C., Wentworth, D.E., Garg, S., Havers, F.P., Fry, A.M., Hall, A.J., Brammer, L., Silk, B.J., 2021. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020-2021. MMWR Morb. Mortal. Wkly. Rep. 70, 1013-1019.
   

10. Palese, P., 2004. Influenza: old and new threats. Nat. Med. 10(Suppl. 12), S82-S87.
    

11. Razzaghi, H., Srivastav, A., Perio, M.A., Laney, A.S., Black, C.L., 2022. Influenza and COVID-19 vaccination coverage among health care personnel-United States, 2021-22. MMWR Morb. Mortal. Wkly. Rep. 71, 1319-1326.
    

12. Sooryanarain, H., Elankumaran, S., 2015. Environmental role in influenza virus outbreaks. Annu. Rev. Anim. Biosci. 3(1), 347-373.
    

13. Whitley, R.J., Boucher, C.A., Lina, B., Nguyen-Van-Tam, J.S., Osterhaus, A., Schutten, M., Monto, A.S., 2013. Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the influenza resistance information study (IRIS). Clin. Infect. Dis. 56, 1197-1205.
    

14. Wilson, I.A, Skehel, J.J., Wiley, D.C., 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289(5796), 366-373.
    

15. World Health Organization (WHO), 2023a. Influenza Laboratory Surveillance Information. [accessed 13 June 2023; Available from: https://www.who.int/tools/flunet.
    

16. World Health Organization (WHO), 2023b. Recommended Composition of Influenza Virus Vaccines for Use in the 2023-2024 Northern Hemisphere Influenza Season. [accessed 13 June 2023; Available from: https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2023-2024-northern-hemisphere-influenza-season.
    

17. Xu, H., Palpant, T., Weinberger, C., Shaw, D.E., 2022. Characterizing receptor flexibility to predict mutations that lead to human adaptation of influenza hemagglutinin. J. Chem. Theor. Comput. 18, 4995-5005.
    

18. Yang, J., Gong, Y., Zhang, C., Sun, J., Wong, G., Shi, W., Liu, W., Gao, G.F., Bi, Y., 2022. Co-existence and co-infection of influenza a viruses and coronaviruses: public health challenges. Innovation. 3, 100306.
    

Proportional views